Fig. 11
From: Safety and efficacy of biological agents in the treatment of Systemic Lupus Erythematosus (SLE)
Change in prednisone dosages to ≤ 7.5 mg and > 25% reduction from baseline dosage
Fig. 11 | BMC Rheumatology
From: Safety and efficacy of biological agents in the treatment of Systemic Lupus Erythematosus (SLE)
Change in prednisone dosages to ≤ 7.5 mg and > 25% reduction from baseline dosage